Abstract
Endocrine-disrupting chemicals (EDCs) in the atmosphere would continue to threaten life as long as human being would breathe air for life. The present chapter deals about the emerging sources of EDCs in the atmosphere, their mode of action at receptor levels, health consequences on prenatal and postnatal exposure, and precautionary measures to reduce exposure to EDCs. The disorders that are discussed include obesity, asthma, male reproductive disorders (hypospadias, cryptorchidism, distortion of semen quality, and prostate cancer), female reproductive disorders (polycystic ovarian syndrome, reproductive tract anomalies, uterine leiomyomas, premature ovarian failure, aneuploidy, breast cancer, endometriosis, and precocious puberty), hypothyroidism, neurodisorders (attention deficit and hyperactivity, autism spectrum, congenital adrenal hyperplasia), lung cancer, diabetes 2, metabolic syndrome, cardiovascular diseases, and neurodegenerative disorder (Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis). The disorders are elucidated based on the mechanism, EDCs involved, epidemiological studies, symptoms, diagnosis, and treatment.
21.1 Air Pollution and Air Pollutants
Over the past decades, rapid industrialization and economic development have been concomitant with large migration from rural areas to cities [1]. This outlook has resulted in urban growth, modernization, and increased concentration of air pollutants, in turn ensuing increased number of exposed people [2]. Atmosphere being a geochemical reservoir of organic compounds partition’s into gaseous and airborne particulate phase that interact with oceans, land, and living organisms [3]. The source and concentration of pollutants in outdoor and indoor atmosphere vary based on point of discharge. The outdoor pollutants are resultant of coal and oil combustion in power plants; disposal of industrial, medical, and municipal solid waste; motor vehicles emissions; industrial and sewage treatment plant discharges; and biomass burning. The causatives of indoor pollutants are unvented combustion, building materials, furnishings, paint, floor and wall coverings, cleaning products, cosmetics, detergents, pesticides, and electronic appliances [4]. The shift-ups in inhaling the above pollutants indeed justify the presence of toxic endocrine-disrupting chemicals (EDCs) body burden in every human being’s blood, urine, and body tissues [5].
21.1.1 Air Pollutants in Terms of EDCs
EDCs are synthetic chemicals used in industrial, agricultural, and household applications, noted for specific property in disrupting endocrine system. On inhaling these chemicals as air particulates, they enter different systems of the body and disrupt normal homeostasis by either mimicking or blocking hormones. EDCs downstream effects start either by interacting with nuclear, hormone, or orphan receptors or by modifying enzymatic pathways involved in steroid biosynthesis or metabolism [6]. The long-range transport of EDCs via atmosphere and ocean routes makes their ubiquitous presence and source of exposure [7]. Distribution of EDCs in the atmosphere is governed by three equilibrium partitioning coefficients: air-water, water-octanol, and octanol-air (Table 21.1).
21.1.2 Major EDCs Causing Pathetic Disorders
chemical production in the preceding 20 years correlates to the growing incidence of endocrine-associated pediatric disorders that include male reproductive disorders, early female puberty, leukemia, brain cancer, and neurobehavioral disorders [5]. Early life exposure to EDCs has also been implicated to the alteration of developmental programming, resulting in higher susceptibility to obesity, respiratory disorders, asthma, diabetes, cancer, endometriosis, neurological disorders, thyroid disorders, and cardiovascular disease [8,9,10,11,12,13,14,15]. The major EDCs involved in all of the above anomalies are phthalate esters (PEs), bisphenol A (BPA), polychlorinated biphenyls (PCBs), polyaromatic hydrocarbons (PAHs), polybrominated flame retardants (BFRs), pesticides, dioxins, alkylphenol (APs), perfluorinated compounds (PFCs), and heavy metals.
21.2 Emerging Sources of EDCs
Numerous chemicals were developed to meet wide range of medical, scientific, agricultural and industrial needs. Despite their socioeconomic benefits, the release of chemicals into the environment and exposure had led to serious health consequences irrespective of ages and species (Fig. 21.1).The source and point of discharge of major EDCs into the atmosphere are as follows:
21.2.1 Phthalates
PEs are dialkyl or alkyl aryl esters of phthalic acid commonly used as plasticizers and encountered as indoor pollutant [47]. They are used in the manufacture of polyvinylchloride (PVC) products, building materials, toys, clothing, cosmetics, perfumes, food packaging, and medical appliances [48]. Phthalates are not physically bound to the polymers making their diffusion easier out of the plastics into the environment. Release of household and industrial wastewater from production and processing units and disposal of materials are sources of phthalates occurring in the atmosphere [49].
21.2.2 Bisphenol A
BPA is an organic compound composed of two phenol rings connected by a methyl bridge, with two methyl functional groups. It is a high-volume production chemical used worldwide in the manufacture of polycarbonate plastics including numerous consumer products like food and water containers and bottles. BPA is also found in the resin linings of food and beverage cans and dental sealants [50], leaching readily from many of these products lead to exposure in large segments of the population [51].
21.2.3 Polychlorinated Biphenyls
PCBs are aromatic, synthetic chemicals formed by two linked benzene rings with some or all of the hydrogen substituted by chlorine atoms. PCBs have been used commercially since 1929 as insulating fluid in transformers, capacitors, and plasticizers in open systems comprising numerous building materials including adhesives, caulk, ceiling tiles, paints, and sealants [52].
21.2.4 Polyaromatic Hydrocarbons
PAHs are a large group of organic compounds with two or more fused aromatic rings. Based on origin, pyrogenic PAHs are formed by the incomplete combustion of fossil fuels, forest fires, and tobacco smoke; petrogenic PAHs are present in crude oil, its product, and coal [53]. PAHs enter the environment primarily through sewage, road runoffs, smelter industries, and oil spills [54, 55]. The offshore PAHs enter water through oil seeps, spills, and discharges from offshore oil installations [56].
21.2.5 Polybrominated Flame Retardants
In ancient Egypt about 450 BC, alum was used to reduce the flammability of wood, and ever since that time flame retardants have been used in various materials. The halogen-containing compounds are used today as flame retardants in electronic equipment, textiles, plastics, paints, and printed circuit boards preventing fire eruptions by capturing free radicals [57].
21.2.6 Pesticides
Pesticides are substances or chemical mixture intended for preventing, destroying, repelling, or lessening the damage of pest (Fig. 21.2). This includes herbicides, insecticides, fungicides, and rodenticides used in agriculture and public health. Occupational exposure to pesticides in agricultural workplace occurs during preparation (mixing and loading) and application (spraying) [58].
21.2.7 Dioxins
Dioxins are a group of 210 organic chemicals, among which 75 congeners are polychlorinated dibenzo-p-dioxins (PCDDs), and 135 are polychlorinated dibenzo-furans (PCDFs). Prior to industrialization, low concentrations of dioxins existed in nature due to natural combustion and geological processes [59]. Presently, in industries though dioxins are not produced commercially, they are formed as by-products when reaction temperature is not well controlled in chemical manufacturing processes [60]. Dioxins are also produced in small concentrations when organic materials are burned in the presence of chlorine ions or atoms in the fuel formulae [61].
21.2.8 Alkylphenol
APs are widely used as nonionic surfactants in detergents, pesticides, herbicides, emulsifiers, paints, cosmetics, plastic ware, and even in jet fuel [62]. They are commonly found in wastewater discharges and effluents from sewage treatment plants [63].
21.2.9 Perfluorinated Compounds
PFCs are synthetic compounds characterized by long, fully fluorinated carbon chains with different functional head groups resisting them to degradation [64]. PFCs are used in variety of products to resist grease, oil, stains, and water and are also used in fire-fighting foam [65]. PFC contamination in the environment originates from direct or indirect anthropogenic sources. Direct source includes manufacture and use of perfluoroalkylated acids (PFAA), whereas indirect sources include product impurities and production of chemicals that may degrade to PFAA [66].
21.2.10 Heavy Metals
Heavy metals are commonly defined as metals those having a specific density of more than 5 g cm3. The main threats to human health from heavy metals are associated with exposure to lead, cadmium, mercury, and arsenic. Heavy metals are being used in many different areas for thousands of years. Lead has been used for at least 5000 years, early applications including building materials, pigments for glazing ceramics, and pipes for transporting water [67]. Cigarette smoke contains about 30 metals, of which cadmium, arsenic, and lead are in the highest concentrations [68].
21.3 Mechanism Behind Endocrine Disruption
EDCs exert numerous disrupting mechanisms interfering endogenous hormonal functions depending on certain factors such as exposure level, duration, age, and susceptibility (Table 21.2). Owing to this action, EDCs are able to disrupt two or more endocrinal functions with widespread consequences on the biological processes controlled by vulnerable endocrine glands. In vivo studies predict activation of hormonal receptors at nanomolar (nM) levels and enzymatic disruption at micromolar (mM) levels resulting in genomic instability and alteration of hormonal feedback regulation [69]. EDCs exert their actions through nuclear hormone receptors such as estrogen receptors (ERs), androgen receptors (ARs), progesterone receptors (PRs), thyroid receptors (TRs), and retinoid receptors (RXR) [6]. Indeed, EDCs are also capable of acting through nonsteroid receptors, transcriptional coactivators, enzymatic pathways, and genomic mechanism [70, 71].
21.3.1 Metabolic Disruption Through Hormone Receptors
Hormone receptors belong to a class of classic hormone receptors that recognize only one or a few molecules with high affinity. Thyroid hormone (TH), mineralocorticoid, glucocorticoid, retinoic acid, estrogen, vitamin D, progesterone, and androgen receptors belong to this class. Interaction of EDCs with these receptors results in developmental and reproductive effects, as well as metabolic alterations.
21.3.1.1 Estrogen Receptor
Estrogen receptors (ERα and β) have well-established roles in reproduction; in addition to that, they are also involved in brain development and function of many other organs such as the skin, bone, and liver (Fig. 21.3). At the molecular level, ERs and estrogens regulate glucose transport, glycolysis, mitochondrial activity, and fatty acid oxidation [94]. Based on experimental evidences, early exposure to BPA enhances adipocyte differentiation or permanently disrupt adipocyte-specific gene expression and leptin synthesis [95, 96]. Estrogenic surfactant octylphenols potentially elevate adipocyte production of resistin through activation of the ER and regulate extracellular signal kinase pathways [97]. Resistin secreted by adipocytes causes insulin resistance and predisposition to type 2 diabetes [98]. BPA also affects ERα activity in the pancreas and increases insulin secretion [99].
21.3.1.2 Thyroid Hormone Receptor and Glucocorticoid Receptor
TH activity is mediated by the TRs, TRα, and β which form heterodimers with RXR to bind the promoter sequences of target genes. Elevated TH levels accelerate metabolism, increase lipolysis and hepatic cholesterol biosynthesis, and provoke weight loss; the exact vice versa exists with low TH levels. In contrast to TR, GR forms homodimers and resides in the cytosol, forming complexes with molecular chaperones, and influences gene expression. Glucocorticoids act through GRs promoting gluconeogenesis, increasing blood glucose levels, and mobilizing the oxidation of fatty acids. Based on experimental evidences, BPA and PEs stimulate GR-mediated lipid accumulation and synergize with a weak GR agonist to increase expression of adipocyte-specific markers [100]. The effects of BPA on TR during development may be significant in long-term body weight increase, while BFRs decrease glucose oxidation, characteristically associated with obesity, insulin resistance, and type 2 diabetes [101, 102].
21.3.2 Metabolic Disruption Through Xenosensors
The body is protected from the accumulation of toxic chemicals by a complex strategy that takes place in the liver, regulating the expression of drug-metabolizing enzymes and transporters. This adaptive response integrates at least three xenosensors: pregnane X receptor (PXR), constitutive androstane receptor (CAR), and aryl hydrocarbon receptor (AhR).
21.3.2.1 Pregnane X Receptor and Constitutive Androstane Receptor
PXR and CAR regulate gene expression by forming heterodimers with RXR that bind to xenobiotic response sequences present in the promoters of their target genes. PXR is located primarily in the nucleus and is strongly activated upon ligand binding. In contrast, in the absence of ligand, CAR is retained in the cytoplasm through association with the cytoplasmic CAR retention protein (CCRP) and heat shock protein 90 (HSP90) [103]. PXR and CAR are highly expressed in the liver and act as master regulators of detoxification pathways [104]. Based on experimental evidence, EDCs such as nonylphenols (NPs), DEHP, MEHP, PCBs, BPA, PFCs PFOA, PFOS, and organochlorine methoxychlor are reported to activate PXR and CAR [105,106,107]. DEHP induces CAR-dependent activation of the nuclear receptor pathway, controlling the cellular clock and functions in energy metabolism [106]. EDC activated PXR and CAR also tends to regulate several CYP (cytochrome P450) family members involved in detoxifying pathways by metabolizing steroids and other endogenous hormones [103].
21.3.2.2 Aryl Hydrocarbon Receptor
AhR is a ligand-activated transcription factor which mainly senses and mediates the toxic effects of dioxins TCDD. The inactivated AhR protein resides in the cytosol and, upon ligand-mediated activation, translocates into the nucleus and heterodimerizes with the ubiquitously expressed aryl hydrocarbon receptor nuclear translocator (ARNT). Then AhR/ARNT complex binds to specific regulatory DNA sequences to regulate gene expression [108]. Recently, AhR has also been implicated as a regulator of energy metabolism, organogenesis, embryonic development, the cell cycle, immunosuppression, and carcinogenicity. Experimental studies report that certain EDCs such as PCBs and TCDD trigger inappropriate activation of AhR unrelated to detoxification. This affects the genes in an AhR-dependent manner linked to hepatic circadian rhythm, cholesterol biosynthesis, fatty acid synthesis, glucose metabolism, and adipocyte differentiation [109, 110]. AhR also disrupts ER signaling pathways by increasing ER proteasomal degradation and modulating estrogen levels via CYP expression and altering ER transcriptional activity [111, 112].
21.3.3 Peroxisome Proliferator-Activated Receptors
PPARs are sensor receptors with large ligand-binding domain that accommodates variety of ligands, primarily lipid derivatives. In presence of ligand, PPARs heterodimerize with RXR and bind to the PPAR response elements localized in the promoter regions of target genes [113]. PPAR is composed of three isotypes: PPARα, β/δ, and γ. PPARα is expressed predominantly in tissues characterized by a high rate of fatty acid catabolism such as the liver, kidney, heart, and muscle. PPARβ shares partially overlapping functions with PPARα and has a role in cell differentiation and survival [114, 115]. PPARγ functions in adipogenesis, lipid storage, inflammatory responses, and the control of insulin sensitivity [116]. Plasticizers, surfactants, pesticides, and dioxins modulate PPAR activity, although fairly little is known about the molecular mechanisms and the physiological outputs involved. In utero exposure induces alterations in fat structure and metabolism, with a disorganization of hepatic and gonadal architecture, steatosis in the liver, and an increase in lipid accumulation and mature adipocytes [117].
21.4 Endocrine System and Determination of EDC’s Dose Response
Available literature and reports suggest that endogenous hormones and EDCs act at extremely low serum concentrations, typically in the picomolar to nanomolar range. But question arises whether the risk assessment studies and animal model studies are certainly able to round off such low dose. Complementally, low-dose effect is defined as any biological change that occurs in the range of typical human exposures or the dose lower than those typically used in standard protocols and toxicology assessments [118]. As an account, endocrine system displays specificity in response to endogenous hormones via hormone receptors that may be found specifically in a single cell or few cell types or throughout the body; e.g., thyroid-stimulating hormone (TSH) receptors are found specifically in thyroid gland, while thyroid hormone (TH) receptors are found throughout the body [119]. The receptors found in multiple cell types may also vary in response or effects as different co-regulators influence the behavior of target genes [120, 121].
Concentrations of active endogenous hormones vary based on the age and physiological status of the individual; for instance, plasma testosterone levels are less than 1 ng mL−1 in male children but increase to approximately 5–7 ng mL−1 in adult; during menses, estradiol levels are typically less than 100 pg mL−1 but, prior ovulation, spikes to 800 pg mL−1 [122, 123]. In addition, it is noted that active concentrations of endogenous hormones vary from species to species and even vary between strains of the same species [124]. Apart from endogenous hormone mechanism, EDCs to which exposure is increasing in day-to-day life also mimic and exert several mechanisms in binding to hormone receptors (Fig. 21.4). Single EDC is able to regulate several pathways; in contrast the atmospheric exposure remains to be mixture of EDCs, and occupational exposure may be of higher dose, the effect of which may vary from low-dose response. Considering all of the above, though oblique statement prevails in determining the mechanism, concentration, and effects of EDCs, the postulated mechanisms, determined toxic levels, and health effects may not be unnoticed.
References
Zhang Y, Mo J, Weschler CJ. Reducing health risks from indoor exposures in rapidly developing urban China. Environ Health Perspect. 2013;121(7):752–5.
United Nations, Department of Economic and Social Affairs, Population Division. World Urbanization Prospects: The 2014 Revision, Highlights (ST/ESA/SER.A/352). 2014.
Fu P, Kawamura K. Uniquity of bisphenol A in the atmosphere. Environ Pollut. 2010;158:3138–43.
Annamalai J, Namasivayam V. Endocrine disrupting chemicals in the atmosphere: their effects on humans and wildlife. Environ Int. 2015;76:78–97.
Gore AC, Crews D, Doan LL, Merrill ML, Patisau Hl, Zota A. Introduction to endocrine disrupting chemicals (EDCs): A guide for public interest organizations and policy-makers. Endocrine Society- Hormone to Health. 2014. p. 1–69.
Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30(4):293–342.
Lohmann R, Breivik K, Dachs J, Muir DG. Global fate of POPs: current and future research directions. Environ Pollut. 2007;150:150–65.
Bruner-Tran KL, Osteen KG. Dioxin-like PCBs and endometriosis. Syst Biol Reprod Med. 2010;56(2):132–46.
Clark NA, Demers PA, Karr CJ, Koehoorn M, Lencar C, Tamburic L, Brauer M. Effect of early life exposure to air pollution on development of childhood asthma. Environ Health Perspect. 2010;118:284–90.
Cock MD, Maas YGH, Bor MVD. Does perinatal exposure to endocrine disruptors induce autism spectrum and attention deficit hyperactivity disorders? Review. Acta Paediatr. 2012;101:811–8.
Garcia-Mayor RV, Vidal AL, Dicet Caamano MF, Gimenez AL. Endocrine disruptors and obesity: obesogens. Endocrinol Nutr. 2012;59(4):261–7.
Kim KH, Jahan SA, Kabir E. A review on human health perspective of air pollution with respect to allergies and asthma. Environ Int. 2013;59:41–52.
Kirkley AG, Sargis RM. Environmental endocrine disruption of energy metabolism and cardiovascular risk. Curr Diab Rep. 2014;14:494.
Kuo CC, Moon K, Thayer KA, Navas-Acien A. Environmental chemicals and type 2 diabetes: an updated systematic review of the epidemiologic evidence. Curr Diab Rep. 2013;13:831–49.
Macon MB, Fenton SE. Endocrine disruptors and the breast: early life effects and later life disease. J Mammary Gland Biol Neoplasia. 2013;18:43–61.
HSDB. Hazardous Substances Data Bank. National Library of Medicine. 2010. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen? HSDB and search on CAS number. Last Accessed 18 July 2010.
ATSDR (Agency for Toxic Substances and Disease Registry). Toxicological profile for di (2-ethyl hexyl) phthalate. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service; 2002.
HSDB (Hazardous Substances Data Bank.National). Library of medicine. 2001. http://toxnet.nlm.nih.gov/cgi- bin/sis/search/a?dbs+hsdb:@term+@DOCNO+922.
EPA. Toxicological review of dibutyl phthalate. External peer review draft. 2006a. http://www.epa.gov/ncea/iris/recent_2006.htm .
Medellin-Castillo NA, Ocampo-Perez R, Leyva-Ramos R, Sanchez-Polo M, Rivera-Utrilla J, Mendez-Diaz JD. Removal of diethyl phthalate from water solution by adsorption, photo-oxidation, ozonation and advanced oxidation process (UV/H2O2, O3/H2O2 and O3/activated carbon). Sci Total Environ. 2013;442:26–35.
WHO (World Health Organization). Diethyl phthalate. Concise International Chemical Assessment Document 52. ISBN 92-4-153052-9 (LC/NLM Classification: QV 612), ISSN 1020–6167. Geneva. 2003.
Safdari M, Golmohammadi H. Prediction of n-octanol-water partition coefficient for polychlorinated biphenyls from theoretical molecular descriptors. Eur J Chem. 2010;1(4):266–75.
Yuyin L, Chunsheng Y, Hongyan L, Zhongsheng Y, Yang W. 3D-QSAr study on half-lives of POPs using CoMFA and CoMSIA. J Environ Sci. 2008;20(12):1433–8.
Mackay D, Shiu WY, Ma KC. Illustrated handbook of physical-chemical properties and environmental fate for organic chemicals: pesticide chemicals, vol. 5. Boca Raton, FL: Lewis; 1997.
Kidd H, James DR. The agrochemicals hand book. 3rd ed. Cambridge: Royal Society of Chemistry Information Services; 1991. p. 6–10.
Earl N, Cartwirght CD, Horrocks SJ, Warboys M, Swift S, Kirton JA, et al. Review of the fate and transport of selected contaminants in the soil environment. United Kingdom: Environment Agency. Technical Report P5–079/TR1. 2004.
HSDB (Hazardous Substances Data Bank). Arsenic, elemental. Canadian Centre for Occupational Health and Safety. U.S. National Library of Medicine. 2004. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB .
HSDB (Hazardous Substances Data Bank). National Library of Medicine, Bethesda, MD (TOMES.CD-ROM Version). 1995. Denver, CO: Micromedex, Indlc.
ATSDR (Agency for Toxic Substances and Disease Registry). Toxicological profile for polycyclic aromatic hydrocarbons. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service; 1995.
ATSDR (Agency for Toxic Substances and Disease Registry). Toxicological profile for polybrominated biphenyls and polybrominated diphenyl ethers. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service; 2004.
Chen G, Bunce NJ. Polybrominated diphenyl ethers as Ah receptor agonists and antagonists. Toxicol Sci. 2003;76:310–20.
WHO IPCS. World Health Organization. International Programme on Chemical Safety. Brominated diphenyl ethers. Environmental Health Criteria 162. ISBN 92-4-157162. Geneva. 1994.
Kelly BC, Ikonomou MG, Blair JD, Morin AE, Gobas FAPC. Food web-specific biomagnification of persistent organic pollutants. Science. 2007;317:236–9.
Arnot J, Gouin T, Mackay D. Development and Application of Models of Chemical Fate in Canada: Practical methods for estimating environmental biodegradation rates. Canadian Environmental Modelling Network Report No. 200503. 2005.
Farmer WJ, Yang M, Letey J. Problems associated with the land disposal of an organic industrial hazardous waste containing HCB: Residual management by land disposal; U.S. Environmental Protection Agency, Report EPA-600/9–76-015, Cincinnatia, Ohio. 1976. p. 177–185.
Lewis NM. Attenuation of Polybrominated Biphenyls and Hexachlorobenzene by Earth Materials Project Summary. U. S. Environmental Protection Agency, Report EPA600/S2-81-191, Cincinnati, Ohio. 1981.
Hansch C, Leo A, Hoekman D. Exploring QSAR: Hydrophobic, Electronic, and Steric Constants. American. 1995.
Hollifield HC. Rapid nephelometric estimate of water solubility of highly insoluble organic chemicals of environmental interest. Bull Environ Contam Toxicol. 1979;23:579–86.
Ripping G. Screening of absorption behavior of new chemicals: natural spoils and model absorptions. Ecotoxicol Environ Saf. 1972;6:236–45.
Mackay D, Shiu WY, Ma KC, Lee SC. Handbook of physical-chemical properties and environmental fate for organic chemicals. In:Halogenated hydrocarbons, vol. 2. Boca Raton, FL: CRC Press/Taylor and Francis Group; 2006.
HSDB. Hazardous Substances Data Bank. 1999. Available online at http://sis.nlm.nih.gov.
SRC (Syracuse Research Corporation). Environmental Fate Data Base (EFDB): CHEMFATE. Database. SRC. Syracuse: NY. 2003. http://www.syrres.com/esc/efdb.htm .
Groshart CP, Okkerman PC, Wassenberg WBA, Pijnenburg, AMCM. Chemical study on Alkylphenols. RIKZ Report 2001.029 Nat. Inst. Coast and Marine Management (RIKZ). 2001.
EPA Factsheet Emerging Contaminants - Perfluorooctane Sulphonate (PFOS) and Perflurooctanoic Acid (PFOA). 2012. www.EPA.gov.
Arnot JA, Gobas FA. A review of bioconcentration factor (BCF) and bioaccumulation factor (BAF) assessments for organic chemicals in aquatic organisms. Environ Rev. 2006;14(4):257–97.
Zhu Z, Zuo Y. Bisphenol A and other alkylphenols in the environment - occurrence, fate, health effects and analytical techniques. Adv Environ Res. 2013;2(3):179–202.
Rudel RA, Camann DE, Spengler JD, Korn LR, Brody JG. Phthalates, alkylphenols, pesticides, polybrominated diphenyl ethers and other endocrine disrupting compounds in indoor air and dust. Environ Sci Technol. 2003;37(20):4543–53.
Wormuth M, Scheringer M, Vollenweider M, Hungerbuhler K. What are the sources of exposure to eight frequently used phthalic acid esters in Europeans? Risk Anal. 2006;26(3):803–24.
Cifci DI, Arikan OA. Occurrence of phthalates in sewage sludge from three wastewater treatment plants in Istanbul, Turkey. Clean (Weinh). 2013;41(9):851–5.
Welshons WV, Nagel SC, vom Saal FS. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology. 2006;147:S56–69.
Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, et al. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect. 2010;118:1055–70.
Thomas K, Xue J, Williams R, Jones P, Whitake D. Polychlorinated Biphenyls (PCBs) in School Buildings: Sources, Environmental Levels, and Exposures. EPA/600/R-12/051. 2012.
Vasudevan N, Aruazhagan P. Surfactants mediated recovery of anthracene and pyrene from contaminated soil. Asian J Microbiol Biotechnol Environ Exp Sci. 2007;9(2):237–42.
Mascarelli A. After the oil. Nature. 2010;467:22–4.
Vasudevan N, Bharathi S, Arulazhagan P. Role of plasmid in the degradation of petroleum hydrocarbon by Pseudomonas fluorescens NS1. J Environ Sci Health. 2007;A42:1141–6.
Kemsley J. Water eased oil removal in Gulf. Chem Eng News Arch. 2012;6:32–3.
Birnbaum LS, Staskal DF. Brominated flame retardants: cause for concern? Environ Health Perspect. 2004;112:9–17.
Khan AA, Ma S, Rahman SU. Occupational exposure to pesticides and its effects on health status of workers in Swat, Khyber Pakhtunkwa, Pakistan. J Biol Life Sci. 2013;4:43–55.
CPCB (Central pollution control board). Study of environmental contamination with polychlorinated. 2007.
CPCB (Central pollution control board). Dioxin (PCDDs) and Furan (PCDFs) - Critical persistent organic pollutants (POPs). Final Report. 2004.
EPA. An Inventory of Sources and Environmental Releases of Dioxin-Like Compounds in the United States for the Years 1987, 1995, and 2000. EPA/600/P-03/002F. Final Report. Nov 2006b.
Cevdet U, Mesude I, Inci T. Alkylphenols in the environment and their adverse effects on living organisms. Kocatepe Vet J. 2009;2(1):49–58.
Chen B, Duan JC, Mai BX, Luo XJ, Yang QS, Sheng GY, et al. Distribution of alkylphenols in the Pearl River Delta and adjacent northern South China Sea, China. Chemosphere. 2006;63(4):652–61.
Fromme H, Tittlemier SA, Volkel W, Wilhelm M, Twardella D. Perfluorinated compounds- exposure assessment for the general population in western countries. Int J Hyg Environ Health. 2009;212:239–70.
Bjorklund JA, Thuresson K, De Wit CA. Perfluoroalkyl compounds (PFCs) in indoor dust: concentrations, human exposure estimates, and sources. Environ Sci Technol. 2009;43:2276–81.
Prevedouros K, Cousins IT, Buck RC. Sources, fate, and transport of perfluorocarboxylates. Environ Sci Technol. 2006;40(1):32–44.
Jarup L. Hazards of heavy metal contamination. Br Med Bull. 2003;69:167–82.
Pizent A, Ariba B, Zivkovic T. Reproductive toxicity of metals in men. Arh Hig Rada Toksikol. 2012;63(1):35–46.
Iguchi T, Katsu Y. Commonality in Signaling of endocrine disruption from snail to human. Bioscience. 2008;58(11):1061–7.
Diamanti-Kandarakis E, Palioura E, Kandarakis SA, Koutsilieris M. The impact of endocrine disruptors on endocrine targets. Horm Metab Res. 2010;42(8):543–52.
Moral R, Wang R, Russo IH, Lamartiniere CA, Pereira J, Russo J. Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. J Endocrinol. 2008;196(1):101–12.
Pie XQ, Song M, Guo M, Mo FF, Shen XY. Concentration and risk assessment of phthalates present in indoor air from newly decorated apartments. Atmos Environ. 2013;68:17–23.
Xie Z, Ebinghaus R, Temme C, Lohmann R, Caba A, Ruck W. Occurrence and Air-Sea exchange of phthalates in the Arctic. Environ Sci Technol. 2007;41:4555–60.
Demircioglu E, Sofuoglu A, Odabasi M. Atmospheric concentrations and phase partitioning of polycyclic aromatic hydrocarbons in Izmir, Turkey. Clean (Weinh). 2011;39:319–27.
Morville S, Delhomme O, Millet M. Seasonal and diurnal variations of atmospheric PAH concentrations between rural, suburban and urban areas. Atmos Pollut Res. 2011;2:366–73.
Sjodin A, Jones RS, Focant JF, Lapeza C, Wang RY, McGhaee EE, et al. Retrospective time-trend study of polybrominated diphenyl ether and polybrominated and polychlorinated biphenyl levels in human serum from the United States. Environ Health Perspect. 2004;112(6):654–8.
Tian M, Chen SJ, Wang J, Luo Y, Luo XJ, Mai BX. Plant uptake of atmospheric brominated flame retardants at an e-waste site in southern China. Environ Sci Technol. 2012;46:2708–14.
Ali N, Harrad S, Goosey E, Neels H, Covaci A. “Novel” brominated flame retardants in Belgian and UK indoor dust: implications for human exposure. Chemosphere. 2011;83(10):1360–5.
Devi NL, Qi S, Chakraborty P, Zhang G, Yadav IC. Passive air sampling of organochlorine pesticides in a northeastern state of India, Manipur. J Environ Sci. 2011;23(5):808–15.
WYGE (WYG Environmental) (Ireland) Ltd. Monitoring of Dioxin and Furan concentrations in the ambient air Haulbowline Island Island, Co. Cork 8: Resource and Environmental Consultants Ltd. 2008.
Ying GG. Fate, behavior and effects of surfactants and their degradation products in the environment. Environ Int. 2006;32(3):417–31.
Saito I, Onuki A, Seto H. Indoor air pollution by alkylphenols in Tokyo. Indoor Air. 2004;14(5):325–32.
Dreyer A, Weinberg I, Temme C, Ebinghaus R. Polyfluorinated compounds in the atmosphere of the Atlantic and southern oceans: evidence for a global distribution. Environ Sci Technol. 2009;43:6507–14.
Barber JL, Berger U, Chaemfa C, Huber S, Jahnke A, Temme C, et al. Analysis of per- and polyfluorinated alkyl substances in air samples from northwest. J Environ Monit. 2007;9:530–41.
Oono S, Matsubara E, Harada KH, Takagi S, Hamada S, Asakava A, et al. Survey of airborne polyfluorinated telomeres in Keihan area, Japan. Bull Environ Contam Toxicol. 2008;80:102–6.
Stock NL, Lau FK, Ellis DA, Martin JW, Muir DCG, Mabury SA. Polyfluorinated telomere alcohols and sulfonamides in the North American troposphere. Environ Sci Technol. 2004;38:991–6.
Jahnke A, Ahrens LR, Ebingham U, Berger Jl, Barber C, Tenense. An improved method for the analysis of volatile polyfluorinated alkyl substances in environmental air samples. Anal Bioanal Chem. 2007; 387: 965–975.
Gilbert SG. A small dose of toxicology: the health effects of common chemicals. 1st ed. Boca Raton, FL: CRC Press; 2004.
Graef JW. ‘Cadmium’ in Harrison’s principles of internal medicine. In: Isselbacher KJ, et al., editors. . 13th ed. New York, NY: McGraw Hill; 1994. p. 2462–3.
Ling B, Han G, Xu Y. PCB levels in humans in an area of PCB transformer recycling. Ann N Y Acad Sci. 2008;1140:135–42.
Goldman R, Enewold L, Pellizzari E, Beach JB, Bowman ED, Krishnan SS, Shields PG. Smoking increases carcinogenic polycyclic aromatic hydrocarbons in human lung tissue. Cancer Res. 2001;61:6367–71.
Sponder M, Fritzer-Szekeres M, Marculescu R, Mittlbock M, Uhl M, Kohler-Vallant B, Strametz-Juranek J. Blood and urine levels of heavy metal pollutants in female and male patients with coronary artery disease. Vasc Health Risk Manag. 2014;10:311–7.
Aas W, Breivik K. Heavy metals and POP measurements 2003. Kjeller, Norwegian Institute for Air Research (EMEP-CCC Report #9/2005). 2005.
Chen JQ, Brown TR, Russo J. Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochim Biophys Acta. 2009;1793:1128–43.
Phrakonkham P, Viengchareun S, Belloir C, Lombes M, Artur Y, Canivenc-Lavier MC. Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis. J Steroid Biochem Mol Biol. 2008;110:95–103.
Wada K, Sakamoto H, Nishikawa K, Sakuma S, Nakajima A, et al. Lifestyle-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome. J Pharmacol Sci. 2007;105:133–7.
Lee MJ, Lin H, Liu CW, Wu MH, Liao WJ, et al. Octylphenol stimulates resisting gene expression in 3T3-L1 adipocytes via the estrogen receptor and extracellular signal-regulated kinase pathways. Am J Physiol Cell Physiol. 2008;294:1542–51.
Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307–12.
Alonso-Magdalena P, Ropero AB, Carrera MP, Cederroth CR, Baquie M, et al. Pancreatic insulin content regulation by the estrogen receptor ERα. PLoS One. 2008;3:e2069.
Sargis RM, Johnson DN, Choudhury RA, Brady MJ. Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity. 2010;18:1283–8.
Legler J. New insights into the endocrine disrupting effects of brominated flame retardants. Chemosphere. 2008;75:216–22.
Zoeller RT, Bansal R, Parris C. Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and altersRC3/neurogran in expression in the developing rat brain. Endocrinology. 2005;146:607–12.
Kretschmer XC, Baldwin WS. CAR and PXR: xenosensors of endocrine disrupters? Chem Biol Interact. 2005;155:111–28.
Wada T, Gao J, Xie W. PXR and CAR in energy metabolism. Trends Endocrinol Metab. 2009;20:273–9.
Eveillard A, Lasserre F, de Tayrac M, Polizzi A, Claus S, et al. Identification of potential mechanisms of toxicity after di-(2-ethylhexyl)-phthalate (DEHP) adult exposure in the liver using a systems biology approach. Toxicol Appl Pharmacol. 2009b;236:282–92.
Eveillard A, Mselli-Lakhal L, Mogha A, Lasserre F, Polizzi A, et al. Di-(2-ethylhexyl)-phthalate (DEHP) activates the constitutive androstane receptor (CAR): a novel signaling pathway sensitive to phthalates. Biochem Pharmacol. 2009a;77:1735–46.
Ren H, Aleksunes LM, Wood C, Vallanat B, George MH, et al. Characterization of peroxisome proliferator-activated receptor α–independent effects of PPARα activators in the rodent liver: di-(2- ethylhexyl) phthalate also activates the constitutive-activated receptor. Toxicol Sci. 2010;113:4–59.
Bock KW, Kohle C. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem Pharmacol. 2006;72:393–404.
Arsenescu V, Arsenescu RI, King V, Swanson H, Cassis LA. Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ Health Perspect. 2008;116:761–8.
Sato S, Shirakawa H, Tomita S, Ohsaki Y, Haketa K, et al. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver. Toxicol Appl Pharmacol. 2008;229:10–9.
Matthews J, Gustafsson JA. Estrogen receptor and aryl hydrocarbon receptor signaling pathways. Nucl Recept Signal. 2006;4:e016.
Swedenborg E, Ruegg J, Makela S, Pongratz I. Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders. J Mol Endocrinol. 2009;43:1–10.
Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the cross roads of key cellular functions. Prog Lipid Res. 2006;45:120–59.
Barish GD, Narkar VA, Evans RM. PPARδ: a dagger in the heart of the metabolic syndrome. J Clin Investig. 2006;14:590–7.
Michalik L, Wahli W. Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease. Biochim Biophys Acta. 2007;1771:991–8.
Auwerx J. PPARγ, the ultimate thrifty gene. Diabetologia. 1999;42:1033–49.
Takeuchi S, Matsuda T, Kobayashi S, Takahashi T, Kojima H. In vitro screening of 200 pesticides for agonistic activity via mouse peroxisome proliferator-activated receptor (PPAR)α and PPARγ and quantitative analysis of in vivo induction pathway. Toxicol Appl Pharmacol. 2006;217:235–44.
Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and non-monotonic dose responses. Endocr Rev. 2012;33(3):378–455.
Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev. 2010;31:139–70.
Fu M, Wang C, Zhang X, Pestell RG. Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem Pharmacol. 2004;68:1199–208.
Kress E, Samarut J, Plateroti M. Thyroid hormones and the control of cell proliferation or cell differentiation: paradox or duality? Mol Cell Endocrinol. 2009;313:36–49.
Jones KA. Summation of basic endocrine data. In: Gass GH, Kaplan HM, editors. Handbook of endocrinology. 2nd ed. New York, NY: CRC Press; 1996. p. 1–42.
Neill JD. Knobil and Neill’s physiology of reproduction. 3rd ed. New York: Academic Press; 2005.
Stokes WS. Selecting appropriate animal models and experimental designs for endocrine disruptor research and testing studies. ILAR J. 2004;45:387–93.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Jayshree, A., Vasudevan, N. (2018). Air Pollution and Endocrine-Disrupting Chemicals. In: Capello, F., Gaddi, A. (eds) Clinical Handbook of Air Pollution-Related Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-62731-1_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-62731-1_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62730-4
Online ISBN: 978-3-319-62731-1
eBook Packages: MedicineMedicine (R0)